Search Results - "Polisson, Richard P"

Validity, reliability, and feasibility of durometer measurements of scleroderma skin disease in a multicenter treatment trial by Merkel, Peter A., Silliman, Nancy P., Denton, Christopher P., Furst, Daniel E., Khanna, Dinesh, Emery, Paul, Hsu, Vivien M., Streisand, James B., Polisson, Richard P., Åkesson, Anita, Coppock, John, van den Hoogen, Frank, Herrick, Ariane, Mayes, Maureen D., Veale, Douglas, Seibold, James R., Black, Carol M., Korn, Joseph H.

“…Objective To determine the validity, reliability, and feasibility of durometer measurements of skin hardness as an outcome measure in clinical trials of…”
Get full text

Case 29-2005: A 68-Year-Old Man with Periorbital Swelling, Rash, and Weakness by Polisson, Richard P, Crocker, Jonathan T, Mueller, Peter R, Harris, Nancy Lee, Duncan, Lyn M

“…A 68-year-old man noted a rash followed by periorbital swelling and muscular weakness. Several months before his hospital admission, he had had involuntary…”
Get full text

The rational initial clinical evaluation of the patient with musculoskeletal complaints by Phillips, A C, Polisson, R P

“…The differentiation of articular from nonarticular complaints and inflammatory from noninflammatory disorders can usually be made by clinical evaluation…”
Get more information

Iliopsoas bursitis: clinical features, radiographic findings, and disease associations by Toohey, A K, LaSalle, T L, Martinez, S, Polisson, R P

“…Inflammation of the iliopsoas bursa is a common manifestation of a wide array of inflammatory, degenerative, and traumatic musculoskeletal conditions. The…”
Get more information

Calcification of entheses associated with X-linked hypophosphatemic osteomalacia by Polisson, R P, Martinez, S, Khoury, M, Harrell, R M, Lyles, K W, Friedman, N, Harrelson, J M, Reisner, E, Drezner, M K

“…We undertook a retrospective analysis of 26 patients with X-linked hypophosphatemic osteomalacia (or rickets), whose ages ranged from 1 to 62 years and who…”
Get more information

Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease by MERKEL, P. A, POLISSON, R. P, CHANG, Y, SKATES, S. J, NILES, J. L

“…Two types of antineutrophil cytoplasmic antibodies (ANCA), antiproteinase 3 antibodies (anti-PR3) and antimyeloperoxidase antibodies (anti-MPO), are useful in…”
Get full text

Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose by Palmer, W E, Rosenthal, D I, Schoenberg, O I, Fischman, A J, Simon, L S, Rubin, R H, Polisson, R P

“…To quantify the activity of joint inflammation with magnetic resonance (MR) imaging and positron emission tomography (PET). Gadolinium-enhanced MR imaging and…”
Get more information

The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases by Merkel, P A, Chang, Y, Pierangeli, S S, Convery, K, Harris, E N, Polisson, R P

“…To determine the prevalence and clinical associations of anticardiolipin antibodies (aCL) in a blinded, controlled study of patients with a variety of…”
Get more information

A man with periorbital swelling, rash, and weakness by POLISSON, Richard P, CROCKER, Jonathan T, MUELLER, Peter R, HARRIS, Nancy Lee, DUNCAN, Lyn M

Get full text

A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus by Ward, M M, Polisson, R P

“…Systemic lupus erythematosus (SLE) with onset in later life has been reported to have a clinical presentation different from that in younger individuals;…”
Get more information

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL: Case 29-2005 by Cabot, Richard C, Harris, Nancy Lee, Shepard, Jo-Anne O, Ebeling, Sally H, Ellender, Stacey M, Peters, Christine C, Polisson, Richard P, Crocker, Jonathan T, Mueller, Peter R, Duncan, Lyn M

“…A 68-year-old man noted a rash followed by periorbital swelling and muscular weakness. Several months before his hospital admission, he had had involuntary…”
Get full text

Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial by Williams, H J, Willkens, R F, Samuelson, Jr, C O, Alarcón, G S, Guttadauria, M, Yarboro, C, Polisson, R P, Weiner, S R, Luggen, M E, Billingsley, L M

“…One hundred eighty-nine patients with rheumatoid arthritis were entered into a prospective, controlled, double-blind multicenter trial comparing placebo and…”
Get more information

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus by Petri, Michelle A., Mease, Philip J., Merrill, Joan T., Lahita, Robert G., Iannini, Mark J., Yocum, David E., Ginzler, Ellen M., Katz, Robert S., Gluck, Oscar S., Genovese, Mark C., Van Vollenhoven, Ronald, Kalunian, Kenneth C., Manzi, Susan, Greenwald, Maria W., Buyon, Jill P., Olsen, Nancy J., Schiff, Michael H., Kavanaugh, Arthur F., Caldwell, Jacques R., Ramsey‐Goldman, Rosalind, St. Clair, E. William, Goldman, Allan L., Egan, Rita M., Polisson, Richard P., Moder, Kevin G., Rothfield, Naomi F., Spencer, Robert T., Hobbs, Kathryn, Fessler, Barri J., Calabrese, Leonard H., Moreland, Larry W., Cohen, Stanley B., Quarles, Betty J., Strand, Vibeke, Gurwith, Marc, Schwartz, Kenneth E.

“…Objective To determine whether prasterone administration results in improvement or stabilization of systemic lupus erythematosus (SLE) disease activity and its…”
Get full text

Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires by Tugwell, P, Bombardier, C, Buchanan, W W, Goldsmith, C, Grace, E, Bennett, K J, Williams, H J, Egger, M, Alarcon, G S, Guttadauria, M

“…In a double-blind, randomized trial of methotrexate vs placebo in rheumatoid arthritis, the effect of treatment on physical, social, and emotional function was…”
Get more information

Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases by Merkel, P A, Chang, Y, Pierangeli, S S, Harris, E N, Polisson, R P

“…Antiphospholipid (aPL) antibodies are present in patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibody syndrome (APS) and are…”
Get more information

A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels by Polisson, R P, Gilkeson, G S, Pyun, E H, Pisetsky, D S, Smith, E A, Simon, L S

“…To evaluate the acute toxicity, potential efficacy, and effects on the soluble interleukin 2 receptor (sIL-2R) of recombinant human interferon gamma…”
Get more information

Risk factors for serious nonsteroidal-induced gastrointestinal complications: regression analysis of the MUCOSA trial by Simon, L S, Hatoum, H T, Bittman, R M, Archambault, W T, Polisson, R P

“…This analysis evaluated the clinical and demographic risk factors for a suspected, serious nonsteroidal anti-inflammatory drug (NSAID)-induced gastrointestinal…”
Get more information

Case records of the Massachusetts General Hospital. Case 29-2005. A 68-year-old man with periorbital swelling, rash, and weakness by Polisson, Richard P, Crocker, Jonathan T, Mueller, Peter R, Harris, Nancy Lee, Duncan, Lyn M

Get full text

NSAIDs and the elderly : Toxicity and economic implications by PHILLIPS, A. C, POLISSON, R. P, SIMON, L. S

“…Despite their propensity to cause toxicity, nonsteroidal anti-inflammatory drugs (NSAIDs) are routinely prescribed for older patients for painful…”
Get full text

Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases by Williams, H J, Alarcón, G S, Neuner, R, Steen, V D, Bulpitt, K, Clegg, D O, Ziminski, C M, Luggen, M E, Polisson, R P, Willkens, R F, Yarboro, C, Morgan, J, Egger, M J, Ward, J R

“…To review the diagnoses after 5 years in patients who were identified within 12 months of the onset of well established and undifferentiated connective tissue…”
Get more information